In CRC progression, FBXL5 has shown to induce cell proliferation, growth, tumorigenesis and inhibit cell apoptosis by modulating PTEN/PI3K/AKT signalling and its overexpression resulted in high tumour formation ability [24,27]. This evidence concerns the gene FBXL5 and colorectal carcinoma.